Wexford Capital’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,861	Closed	-$34.2K	–	213
2024 Q3	$34.2K	Buy	34,861 +15,000	+76%	+$14.7K	0.01%	163
2024 Q2	$30.2K	Buy	+19,861	New	+$30.2K	0.01%	181